Catalent Inc (CTLT) Stock Fundamental Analysis

NYSE:CTLT • US1488061029

63.48 USD
0 (0%)
At close: Dec 17, 2024
63.5 USD
+0.02 (+0.03%)
After Hours: 12/17/2024, 8:52:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall CTLT gets a fundamental rating of 3 out of 10. We evaluated CTLT against 193 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of CTLT have multiple concerns. CTLT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • CTLT had positive earnings in the past year.
  • CTLT had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: CTLT reported negative net income in multiple years.
  • In the past 5 years CTLT always reported a positive cash flow from operatings.
CTLT Yearly Net Income VS EBIT VS OCF VS FCFCTLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

  • The Return On Assets of CTLT (-4.25%) is better than 78.01% of its industry peers.
  • CTLT has a better Return On Equity (-11.66%) than 75.92% of its industry peers.
Industry RankSector Rank
ROA -4.25%
ROE -11.66%
ROIC N/A
ROA(3y)-2.82%
ROA(5y)-0.09%
ROE(3y)-8.14%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
CTLT Yearly ROA, ROE, ROICCTLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

  • Looking at the Gross Margin, with a value of 21.82%, CTLT is in line with its industry, outperforming 51.83% of the companies in the same industry.
  • CTLT's Gross Margin has declined in the last couple of years.
  • CTLT does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.68%
GM growth 5Y-7.41%
CTLT Yearly Profit, Operating, Gross MarginsCTLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • CTLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CTLT has been increased compared to 1 year ago.
  • Compared to 5 years ago, CTLT has more shares outstanding
  • The debt/assets ratio for CTLT is higher compared to a year ago.
CTLT Yearly Shares OutstandingCTLT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CTLT Yearly Total Debt VS Total AssetsCTLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • CTLT has an Altman-Z score of 1.62. This is a bad value and indicates that CTLT is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.62, CTLT is in the better half of the industry, outperforming 64.92% of the companies in the same industry.
  • CTLT has a debt to FCF ratio of 49.84. This is a negative value and a sign of low solvency as CTLT would need 49.84 years to pay back of all of its debts.
  • CTLT's Debt to FCF ratio of 49.84 is fine compared to the rest of the industry. CTLT outperforms 78.01% of its industry peers.
  • A Debt/Equity ratio of 1.38 is on the high side and indicates that CTLT has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.38, CTLT is not doing good in the industry: 74.87% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 49.84
Altman-Z 1.62
ROIC/WACCN/A
WACC9.31%
CTLT Yearly LT Debt VS Equity VS FCFCTLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

  • A Current Ratio of 2.51 indicates that CTLT has no problem at all paying its short term obligations.
  • CTLT has a Current ratio of 2.51. This is comparable to the rest of the industry: CTLT outperforms 46.07% of its industry peers.
  • CTLT has a Quick Ratio of 1.93. This is a normal value and indicates that CTLT is financially healthy and should not expect problems in meeting its short term obligations.
  • CTLT has a Quick ratio (1.93) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.51
Quick Ratio 1.93
CTLT Yearly Current Assets VS Current LiabilitesCTLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. Growth

3.1 Past

  • The earnings per share for CTLT have decreased strongly by -61.40% in the last year.
  • CTLT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -33.48% yearly.
  • Looking at the last year, CTLT shows a small growth in Revenue. The Revenue has grown by 4.71% in the last year.
  • The Revenue has been growing by 11.71% on average over the past years. This is quite good.
EPS 1Y (TTM)-61.4%
EPS 3Y-56.51%
EPS 5Y-33.48%
EPS Q2Q%-30%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y3.1%
Revenue growth 5Y11.71%
Sales Q2Q%4.18%

3.2 Future

  • Based on estimates for the next years, CTLT will show a very strong growth in Earnings Per Share. The EPS will grow by 73.38% on average per year.
  • Based on estimates for the next years, CTLT will show a small growth in Revenue. The Revenue will grow by 7.44% on average per year.
EPS Next Y350.55%
EPS Next 2Y148.11%
EPS Next 3Y113.64%
EPS Next 5Y73.38%
Revenue Next Year8.33%
Revenue Next 2Y8.2%
Revenue Next 3Y8.33%
Revenue Next 5Y7.44%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CTLT Yearly Revenue VS EstimatesCTLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B
CTLT Yearly EPS VS EstimatesCTLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 288.55, the valuation of CTLT can be described as expensive.
  • 78.01% of the companies in the same industry are more expensive than CTLT, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 26.83, CTLT is valued quite expensively.
  • With a Price/Forward Earnings ratio of 41.25, CTLT can be considered very expensive at the moment.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CTLT indicates a somewhat cheap valuation: CTLT is cheaper than 76.44% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of CTLT to the average of the S&P500 Index (24.95), we can say CTLT is valued expensively.
Industry RankSector Rank
PE 288.55
Fwd PE 41.25
CTLT Price Earnings VS Forward Price EarningsCTLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CTLT indicates a somewhat cheap valuation: CTLT is cheaper than 76.96% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CTLT indicates a somewhat cheap valuation: CTLT is cheaper than 78.53% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 116.39
EV/EBITDA 36.47
CTLT Per share dataCTLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CTLT's earnings are expected to grow with 113.64% in the coming years.
PEG (NY)0.82
PEG (5Y)N/A
EPS Next 2Y148.11%
EPS Next 3Y113.64%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • CTLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

Catalent Inc

NYSE:CTLT (12/17/2024, 8:52:12 PM)

After market: 63.5 +0.02 (+0.03%)

63.48

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-05
Earnings (Next)02-07
Inst Owners92.2%
Inst Owner Change0%
Ins Owners0.48%
Ins Owner Change0%
Market Cap11.52B
Revenue(TTM)4.42B
Net Income(TTM)-413.00M
Analysts52.86
Price Target64.77 (2.03%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-149.78%
Min EPS beat(2)-336.02%
Max EPS beat(2)36.46%
EPS beat(4)1
Avg EPS beat(4)-365.14%
Min EPS beat(4)-1032.86%
Max EPS beat(4)36.46%
EPS beat(8)2
Avg EPS beat(8)-208.81%
EPS beat(12)5
Avg EPS beat(12)-141.22%
EPS beat(16)9
Avg EPS beat(16)-103.51%
Revenue beat(2)1
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-5.19%
Max Revenue beat(2)4.16%
Revenue beat(4)1
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-6.04%
Max Revenue beat(4)4.16%
Revenue beat(8)4
Avg Revenue beat(8)0.21%
Revenue beat(12)6
Avg Revenue beat(12)-0.33%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)0.11%
PT rev (3m)4.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.12%
EPS NY rev (1m)4.18%
EPS NY rev (3m)-6.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.9%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.69%
Valuation
Industry RankSector Rank
PE 288.55
Fwd PE 41.25
P/S 2.61
P/FCF 116.39
P/OCF 28.88
P/B 3.25
P/tB 31.57
EV/EBITDA 36.47
EPS(TTM)0.22
EY0.35%
EPS(NY)1.54
Fwd EY2.42%
FCF(TTM)0.55
FCFY0.86%
OCF(TTM)2.2
OCFY3.46%
SpS24.36
BVpS19.51
TBVpS2.01
PEG (NY)0.82
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.25%
ROE -11.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.82%
FCFM 2.24%
ROA(3y)-2.82%
ROA(5y)-0.09%
ROE(3y)-8.14%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.68%
GM growth 5Y-7.41%
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 1.38
Debt/FCF 49.84
Debt/EBITDA 11.05
Cap/Depr 61.22%
Cap/Sales 6.78%
Interest Coverage N/A
Cash Conversion 90.27%
Profit Quality N/A
Current Ratio 2.51
Quick Ratio 1.93
Altman-Z 1.62
F-Score5
WACC9.31%
ROIC/WACCN/A
Cap/Depr(3y)125.99%
Cap/Depr(5y)159.79%
Cap/Sales(3y)11.57%
Cap/Sales(5y)13.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-61.4%
EPS 3Y-56.51%
EPS 5Y-33.48%
EPS Q2Q%-30%
EPS Next Y350.55%
EPS Next 2Y148.11%
EPS Next 3Y113.64%
EPS Next 5Y73.38%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y3.1%
Revenue growth 5Y11.71%
Sales Q2Q%4.18%
Revenue Next Year8.33%
Revenue Next 2Y8.2%
Revenue Next 3Y8.33%
Revenue Next 5Y7.44%
EBIT growth 1Y-166.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year196.68%
EBIT Next 3Y58.17%
EBIT Next 5Y41.23%
FCF growth 1Y121.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y116.85%
OCF growth 3Y-14.78%
OCF growth 5Y1.59%

Catalent Inc / CTLT FAQ

What is the ChartMill fundamental rating of Catalent Inc (CTLT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CTLT.


What is the valuation status of Catalent Inc (CTLT) stock?

ChartMill assigns a valuation rating of 4 / 10 to Catalent Inc (CTLT). This can be considered as Fairly Valued.


Can you provide the profitability details for Catalent Inc?

Catalent Inc (CTLT) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for CTLT stock?

The Price/Earnings (PE) ratio for Catalent Inc (CTLT) is 288.55 and the Price/Book (PB) ratio is 3.25.


What is the expected EPS growth for Catalent Inc (CTLT) stock?

The Earnings per Share (EPS) of Catalent Inc (CTLT) is expected to grow by 350.55% in the next year.